Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A- induced deficits in navigational memory in rats

Jing Liu, Wing Lok Ho, Nelson Tze Kin Lee, Paul R. Carlier, Yuan-Ping Pang, Yi Fan Han

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The novel dimer bis(7)-tacrine (1,7-N-Heptylene-bis-9,9'-amino-1,2,3,4- tetrahydroacridine), which exhibits higher potency, selectivity and oral activity on acetylcholinesterase inhibition in vivo than tacrine, was evaluated for its ability to reverse AF64A-induced spatial memory impairment in rats using the Morris water maze. The intracerebroventricular injection of AF64A (3 nmol/side) resulted in a substantial increase in the escape latency to find the platform (F(1,7) = 30.2, P < 0.01). The observed impairment of spatial memory was paralleled by a 47% decrease in choline acetyltransferase activity in the hippocampus. Oral administration of bis(7)-tacrine (0.22-0.89 μmol/kg) dose-dependently reversed the AF64A-induced latency delay to the level of the saline control group (F(4,28) = 7.45, P < 0.05). The present study provides additional evidence of bis(7)-tacrine as an ideal candidate for the palliative treatment of Alzheimer's disease. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish (US)
Pages (from-to)165-168
Number of pages4
JournalNeuroscience Letters
Volume282
Issue number3
DOIs
StatePublished - Mar 24 2000

Fingerprint

Cholinesterase Inhibitors
Tacrine
Aptitude
Choline O-Acetyltransferase
Acetylcholinesterase
Palliative Care
Oral Administration
Hippocampus
Alzheimer Disease
Control Groups
Injections
1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydroacridine
ethylcholine aziridinium
Water
Spatial Memory

Keywords

  • AF64A
  • Alzheimer's disease
  • Bis(7)-tacrine
  • Cholinesterase inhibitors
  • Water maze

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A- induced deficits in navigational memory in rats. / Liu, Jing; Ho, Wing Lok; Lee, Nelson Tze Kin; Carlier, Paul R.; Pang, Yuan-Ping; Han, Yi Fan.

In: Neuroscience Letters, Vol. 282, No. 3, 24.03.2000, p. 165-168.

Research output: Contribution to journalArticle

Liu, Jing ; Ho, Wing Lok ; Lee, Nelson Tze Kin ; Carlier, Paul R. ; Pang, Yuan-Ping ; Han, Yi Fan. / Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A- induced deficits in navigational memory in rats. In: Neuroscience Letters. 2000 ; Vol. 282, No. 3. pp. 165-168.
@article{6d0fc080473f4c40a84666cdc2eee96c,
title = "Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A- induced deficits in navigational memory in rats",
abstract = "The novel dimer bis(7)-tacrine (1,7-N-Heptylene-bis-9,9'-amino-1,2,3,4- tetrahydroacridine), which exhibits higher potency, selectivity and oral activity on acetylcholinesterase inhibition in vivo than tacrine, was evaluated for its ability to reverse AF64A-induced spatial memory impairment in rats using the Morris water maze. The intracerebroventricular injection of AF64A (3 nmol/side) resulted in a substantial increase in the escape latency to find the platform (F(1,7) = 30.2, P < 0.01). The observed impairment of spatial memory was paralleled by a 47{\%} decrease in choline acetyltransferase activity in the hippocampus. Oral administration of bis(7)-tacrine (0.22-0.89 μmol/kg) dose-dependently reversed the AF64A-induced latency delay to the level of the saline control group (F(4,28) = 7.45, P < 0.05). The present study provides additional evidence of bis(7)-tacrine as an ideal candidate for the palliative treatment of Alzheimer's disease. (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "AF64A, Alzheimer's disease, Bis(7)-tacrine, Cholinesterase inhibitors, Water maze",
author = "Jing Liu and Ho, {Wing Lok} and Lee, {Nelson Tze Kin} and Carlier, {Paul R.} and Yuan-Ping Pang and Han, {Yi Fan}",
year = "2000",
month = "3",
day = "24",
doi = "10.1016/S0304-3940(00)00905-8",
language = "English (US)",
volume = "282",
pages = "165--168",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A- induced deficits in navigational memory in rats

AU - Liu, Jing

AU - Ho, Wing Lok

AU - Lee, Nelson Tze Kin

AU - Carlier, Paul R.

AU - Pang, Yuan-Ping

AU - Han, Yi Fan

PY - 2000/3/24

Y1 - 2000/3/24

N2 - The novel dimer bis(7)-tacrine (1,7-N-Heptylene-bis-9,9'-amino-1,2,3,4- tetrahydroacridine), which exhibits higher potency, selectivity and oral activity on acetylcholinesterase inhibition in vivo than tacrine, was evaluated for its ability to reverse AF64A-induced spatial memory impairment in rats using the Morris water maze. The intracerebroventricular injection of AF64A (3 nmol/side) resulted in a substantial increase in the escape latency to find the platform (F(1,7) = 30.2, P < 0.01). The observed impairment of spatial memory was paralleled by a 47% decrease in choline acetyltransferase activity in the hippocampus. Oral administration of bis(7)-tacrine (0.22-0.89 μmol/kg) dose-dependently reversed the AF64A-induced latency delay to the level of the saline control group (F(4,28) = 7.45, P < 0.05). The present study provides additional evidence of bis(7)-tacrine as an ideal candidate for the palliative treatment of Alzheimer's disease. (C) 2000 Elsevier Science Ireland Ltd.

AB - The novel dimer bis(7)-tacrine (1,7-N-Heptylene-bis-9,9'-amino-1,2,3,4- tetrahydroacridine), which exhibits higher potency, selectivity and oral activity on acetylcholinesterase inhibition in vivo than tacrine, was evaluated for its ability to reverse AF64A-induced spatial memory impairment in rats using the Morris water maze. The intracerebroventricular injection of AF64A (3 nmol/side) resulted in a substantial increase in the escape latency to find the platform (F(1,7) = 30.2, P < 0.01). The observed impairment of spatial memory was paralleled by a 47% decrease in choline acetyltransferase activity in the hippocampus. Oral administration of bis(7)-tacrine (0.22-0.89 μmol/kg) dose-dependently reversed the AF64A-induced latency delay to the level of the saline control group (F(4,28) = 7.45, P < 0.05). The present study provides additional evidence of bis(7)-tacrine as an ideal candidate for the palliative treatment of Alzheimer's disease. (C) 2000 Elsevier Science Ireland Ltd.

KW - AF64A

KW - Alzheimer's disease

KW - Bis(7)-tacrine

KW - Cholinesterase inhibitors

KW - Water maze

UR - http://www.scopus.com/inward/record.url?scp=0034708402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034708402&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(00)00905-8

DO - 10.1016/S0304-3940(00)00905-8

M3 - Article

C2 - 10717417

AN - SCOPUS:0034708402

VL - 282

SP - 165

EP - 168

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -